The drug manufacturing giant is keen on investments in efficiency and new range of products. Earnings Results Q1 FY23 Divi’s Laboratories reported a profit ofView More
PATHFINDERS TRAININGS
unlocking your potential
The drug manufacturing giant is keen on investments in efficiency and new range of products. Earnings Results Q1 FY23 Divi’s Laboratories reported a profit ofView More